INR 1456.8
(-2.39%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 228.1 Million INR | -16.53% |
2022 | 273.28 Million INR | 23.03% |
2021 | 222.12 Million INR | 16.03% |
2020 | 191.43 Million INR | -35.84% |
2019 | 298.37 Million INR | 4.54% |
2018 | 285.42 Million INR | -39.9% |
2017 | 474.87 Million INR | 107.61% |
2016 | 228.73 Million INR | -40.56% |
2015 | 384.82 Million INR | -7.75% |
2014 | 417.13 Million INR | 32.42% |
2013 | 315.01 Million INR | 40.62% |
2012 | 224.01 Million INR | 24.32% |
2011 | 180.18 Million INR | 45.22% |
2010 | 124.08 Million INR | -13.1% |
2009 | 142.79 Million INR | -5.8% |
2008 | 151.58 Million INR | 14.56% |
2007 | 132.31 Million INR | -3.78% |
2006 | 137.5 Million INR | 1.44% |
2005 | 135.55 Million INR | -33.56% |
2004 | 204.02 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2024 Q2 | 301.12 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 248.92 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 228.1 Million INR | -16.53% |
2023 Q4 | 228.1 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 235.58 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 273.28 Million INR | 23.03% |
2022 Q4 | 273.28 Million INR | 0.0% |
2021 FY | 222.12 Million INR | 16.03% |
2021 Q4 | 222.12 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 63.01 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 205.25 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 191.43 Million INR | -35.84% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 191.43 Million INR | 0.0% |
2019 Q4 | 298.37 Million INR | 0.0% |
2019 FY | 298.37 Million INR | 4.54% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 306.05 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q2 | 293.76 Million INR | 0.0% |
2018 FY | 285.42 Million INR | -39.9% |
2018 Q1 | - INR | -100.0% |
2018 Q4 | 285.42 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2017 Q4 | 474.87 Million INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 222.8 Million INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 FY | 474.87 Million INR | 107.61% |
2016 Q1 | - INR | -100.0% |
2016 FY | 228.73 Million INR | -40.56% |
2016 Q4 | 228.73 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 23488.58 Billion INR | 0.0% |
2015 FY | 384.82 Million INR | -7.75% |
2015 Q1 | - INR | -100.0% |
2015 Q4 | 384.82 Million INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 382.91 Million INR | 0.0% |
2014 Q2 | 413.78 Million INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 417.13 Million INR | 32.42% |
2014 Q4 | 417.13 Million INR | 0.0% |
2013 Q2 | 235.04 Million INR | 0.0% |
2013 FY | 315.01 Million INR | 40.62% |
2013 Q1 | - INR | -100.0% |
2013 Q4 | 315.01 Million INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2012 FY | 224.01 Million INR | 24.32% |
2012 Q4 | 224.01 Million INR | 0.0% |
2011 FY | 180.18 Million INR | 45.22% |
2011 Q4 | 180.18 Million INR | 0.0% |
2010 FY | 124.08 Million INR | -13.1% |
2009 FY | 142.79 Million INR | -5.8% |
2008 FY | 151.58 Million INR | 14.56% |
2007 FY | 132.31 Million INR | -3.78% |
2006 FY | 137.5 Million INR | 1.44% |
2005 FY | 135.55 Million INR | -33.56% |
2004 FY | 204.02 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott India Limited | 832.3 Million INR | 72.593% |
Cipla Limited | 5.59 Billion INR | 95.922% |
Gland Pharma Limited | 3.72 Billion INR | 93.871% |
GlaxoSmithKline Pharmaceuticals Limited | 186.65 Million INR | -22.211% |
Kopran Limited | 992.28 Million INR | 77.012% |
Marksans Pharma Limited | 2.44 Billion INR | 90.654% |
NGL Fine-Chem Limited | 324.42 Million INR | 29.689% |
Pfizer Limited | 945.4 Million INR | 75.872% |
Sanofi India Limited | 190 Million INR | -20.056% |
SMS Pharmaceuticals Limited | 2.8 Billion INR | 91.876% |